title: [Kawasaki disease epidemiology in Guadeloupe].
abstract: OBJECTIVE
  To study the incidence of Kawasaki disease in the population of the French West Indies.
  
  
  METHODS
  Fifty-six children where enrolled between January 1, 1995 and December 31, 2000), in this retrospective study in Guadeloupe (French West Indies), according to the diagnostic criteria of the American Heart Association.
  
  
  RESULTS
  There were 31 boys and 25 girls. Their mean age at the time of diagnosis was 26.5 +/- 22 months. The mean incidence was 25.4/100 000 children aged under 5, per year. Cardiac involvement was noted in 17.8% of the cases during the first 3 months, with good outcome in all the children followed-up.
  
  
  CONCLUSIONS
  The incidence of Kawasaki disease in Guadeloupe is high. The absence of epidemiological, clinical or biological predictive criteria of cardiac involvement should prompt the early use of immunoglobulins, notably in atypical presentations of the disease.
authors.affiliation: Service de médecine néonatale et réanimation pédiatrique polyvalente, Hôpital Nord, CHU Amiens. pierre_tourneux@hotmail.com
authors.forename: Pierre
authors.initials: P
authors.lastname: Tourneux
authors.forename: Denis
authors.initials: D
authors.lastname: Dufillot
authors.forename: Marie
authors.initials: M
authors.lastname: Belloy
authors.forename: Franck
authors.initials: F
authors.lastname: Boralevi
authors.forename: Lorena
authors.initials: L
authors.lastname: Cevallos
authors.forename: Gérard
authors.initials: G
authors.lastname: Krim
mesh_terms: D017677:Age Distribution; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004452:Echocardiography; D005260:Female; D005334:Fever / Q000209:etiology; D019430:Guadeloupe / Q000453:epidemiology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D015994:Incidence; D007223:Infant; D007964:Leukocytosis / Q000209:etiology; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D018579:Patient Selection; D011159:Population Surveillance; D012189:Retrospective Studies; D012307:Risk Factors; D012621:Seasons; D017678:Sex Distribution; D013922:Thrombocytosis / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016756:Immunoglobulins, Intravenous; D001241:Aspirin